Expression of miR-33 from an SREBP2 intron inhibits the expression of the fatty acid oxidation-regulatory genes CROT and HADHB in chicken liver

References

• Bartel, D. P. 2009. “MicroRNAs: Target Recognition and Regulatory Functions.” Cell 136: 215–233. doi:10.1016/j.cell.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Brown, M. S., and J. L. Goldstein. 1999. “A Proteolytic Pathway that Controls the Cholesterol Content of Membranes, Cells, and Blood.” Proceedings of the National Academy of Sciences of the United States of America, 96, 11041–11048.
   PubMed Web of Science ®Google Scholar
• Chen, J., M. E. Young, J. C. Chatham, D. K. Crossman, L. J. Dell’Italia, and A. Shalev. 2016. “TXNIP Regulates Myocardial Fatty Acid Oxidation via miR-33a Signaling.” American Journal of Physiology Heart and Circulatory Physiology 311: H64–75. doi:10.1152/ajpheart.00151.2016.
   PubMed Web of Science ®Google Scholar
• Church, C., S. Lee, E. A. Bagg, J. S. McTaggart, R. Deacon, T. Gerken, A. Lee, F. M. Ashcrof, and R. D. Cox. 2009. “A Mouse Model for the Metabolic Effects of the Human Fat Mass and Obesity Associated FTO Gene.” PLoS Genetics 5: e1000599. doi:10.1371/journal.pgen.1000599.
   PubMed Web of Science ®Google Scholar
• Church, C., L. Moir, F. McMurray, C. Girard, G. T. Banks, L. Teboul, S. Wells, F. M. Ashcrof, and R. D. Cox. 2010. “Overexpression of Fto Leads to Increased Food Intake and Results in Obesity.” Nature Genetics 42: 1086–1092. doi:10.1038/ng.713.
   PubMed Web of Science ®Google Scholar
• Eaton, S., T. Bursby, B. Middleton, M. Pourfarzam, K. Mills, A. W. Johnson, and K. Bartlett. 2000. “The Mitochondrial Trifunctional Protein: Centre of a Beta-Oxidation Metabolon?” Biochemical Society Transactions 28: 177–182.
   PubMed Web of Science ®Google Scholar
• Ferdinandusse, S., J. Mulders, I. J. L, S. Denis, G. Dacremont, H. R. Waterham, and R. J. Wanders. 1999. “Molecular Cloning and Expression of Human Carnitine Octanoyltransferase: Evidence for Its Role in the Peroxisomal Beta-Oxidation of Branched-Chain Fatty Acids.” Biochemical and Biophysical Research Communications 263: 213–218. doi:10.1006/bbrc.1999.1340.
   PubMed Web of Science ®Google Scholar
• Gerin, I., G. T. Bommer, C. S. McCoin, K. M. Sousa, V. Krishnan, and O. A. MacDougald. 2010. “Roles for miRNA-378/378* in Adipocyte Gene Expression and Lipogenesis.” American Journal of Physiology Endocrinology and Metabolism 299: E198–206. doi:10.1152/ajpendo.00179.2010.
   PubMed Web of Science ®Google Scholar
• Hermier, D. 1997. “Lipoprotein Metabolism and Fattening in Poultry.” The Journal of Nutrition 127: 805S–808S. doi:10.1093/jn/127.5.805S.
   PubMed Web of Science ®Google Scholar
• Ibdah, J. A., P. Perlegas, Y. Zhao, J. Angdisen, H. Borgerink, M. K. Shadoan, J. D. Wagner, D. Matern, P. Rinaldo, and J. M. Cline. 2005. “Mice Heterozygous for a Defect in Mitochondrial Trifunctional Protein Develop Hepatic Steatosis and Insulin Resistance.” Gastroenterology 128: 1381–1390.
   PubMed Web of Science ®Google Scholar
• Iliopoulos, D., K. Drosatos, Y. Hiyama, I. J. Goldberg, and V. I. Zannis. 2010. “MicroRNA-370 Controls the Expression of microRNA-122 and Cpt1alpha and Affects Lipid Metabolism.” Journal of Lipid Research 51: 1513–1523. doi:10.1194/jlr.M004812.
   PubMed Web of Science ®Google Scholar
• Jia, G., C. Yang, S. Yang, X. Jian, C. Yi, Z. Qiang, and H. Chuan. 2008. “Oxidative Demethylation of 3-Methylthymine and 3-Methyluracil in Single-Stranded DNA and RNA by Mouse and Human FTO.” FEBS letters 582: 3313–3319. doi:10.1016/j.febslet.2008.08.019.
   PubMed Web of Science ®Google Scholar
• Kao, H. J., C. F. Cheng, Y. H. Chen, S. I. Hung, C. C. Huang, D. Millington, T. Kikuchi, J. Y. Wu, and Y. T. Chen. 2006. “ENU Mutagenesis Identifies Mice with Cardiac Fibrosis and Hepatic Steatosis Caused by a Mutation in the Mitochondrial Trifunctional Protein Beta-Subunit.” Human Molecular Genetics 15: 3569–3577. doi:10.1093/hmg/ddl433.
   PubMed Web of Science ®Google Scholar
• Karunakaran, D., L. Richards, M. Geoffrion, D. Barrette, R. J. Gotfrit, M. E. Harper, and K. J. Rayner. 2015. “Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.” Arteriosclerosis, Thrombosis, and Vascular Biology 35: 2536–2543. doi:10.1161/ATVBAHA.115.306404.
   PubMed Web of Science ®Google Scholar
• Kim, J., H. Yoon, C. M. Ramirez, S. M. Lee, H. S. Hoe, C. Fernandez-Hernando, and J. Kim. 2012. “MiR-106b Impairs Cholesterol Efflux and Increases Abeta Levels by Repressing ABCA1 Expression.” Experimental Neurology 235: 476–483. doi:10.1016/j.expneurol.2011.11.010.
   PubMed Web of Science ®Google Scholar
• Kloosterman, W. P., and R. H. Plasterk. 2006. “The Diverse Functions of microRNAs in Animal Development and Disease.” Developmental Cell 11: 441–450. doi:10.1016/j.devcel.2006.09.009.
   PubMed Web of Science ®Google Scholar
• Lanford, R. E., E. S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M. E. Munk, S. Kauppinen, and H. Orum. 2010. “Therapeutic Silencing of microRNA-122 in Primates with Chronic Hepatitis C Virus Infection.” Science 327: 198–201. doi:10.1126/science.1178178.
   PubMed Web of Science ®Google Scholar
• Lin, Q., Z. Gao, R. M. Alarcon, J. Ye, and Z. Yun. 2009. “A Role of miR-27 in the Regulation of Adipogenesis.” The FEBS Journal 276: 2348–2358.
   PubMed Web of Science ®Google Scholar
• Marquart, T. J., R. M. Allen, D. S. Ory, and A. Baldan. 2010. “miR-33 Links SREBP-2 Induction to Repression of Sterol Transporters.” Proceedings of the National Academy of Sciences of the United States of America, 107, 12228–12232. doi:10.1073/pnas.1005191107
   PubMed Web of Science ®Google Scholar
• Najafi-Shoushtari, S. H., F. Kristo, Y. Li, T. Shioda, D. E. Cohen, R. E. Gerszten, and A. M. Naar. 2010. “MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis.” Science 328: 1566–1569. doi:10.1126/science.1189123.
   PubMed Web of Science ®Google Scholar
• Rayner, K. J., C. C. Esau, F. N. Hussain, A. L. McDaniel, S. M. Marshall, J. M. van Gils, T. D. Ray, et al. 2011a. “Inhibition of miR-33a/b in Non-Human Primates Raises Plasma HDL and Lowers VLDL Triglycerides”. Nature 478: 404–407. doi:10.1038/nature10486.
   PubMed Web of Science ®Google Scholar
• Rayner, K. J., F. J. Sheedy, C. C. Esau, F. N. Hussain, R. E. Temel, S. Parathath, J. M. van Gils, et al. 2011b. “Antagonism of miR-33 in Mice Promotes Reverse Cholesterol Transport and Regression of Atherosclerosis”. The Journal of Clinical Investigation 121: 2921–2931. doi:10.1172/JCI57275.
   PubMed Web of Science ®Google Scholar
• Rayner, K. J., Y. Suarez, A. Davalos, S. Parathath, M. L. Fitzgerald, N. Tamehiro, E. A. Fisher, K. J. Moore, and C. Fernandez-Hernando. 2010. “MiR-33 Contributes to the Regulation of Cholesterol Homeostasis.” Science 328: 1570–1573. doi:10.1126/science.1189862.
   PubMed Web of Science ®Google Scholar
• Sanchez-Pulido, L., and M. A. Andrade-Navarro. 2007. “The FTO (Fat Mass and Obesity Associated) Gene Codes for a Novel Member of the Non-Heme Dioxygenase Superfamily.” BMC biochemistry 8: 23. doi:10.1186/1471-2091-8-23.
   PubMedGoogle Scholar
• Sato, R., J. Inoue, Y. Kawabe, T. Kodama, T. Takano, and M. Maeda. 1996. “Sterol-Dependent Transcriptional Regulation of Sterol Regulatory Element-Binding Protein-2.” The Journal of Biological Chemistry 271: 26461–26464.
   PubMed Web of Science ®Google Scholar
• Seo, Y. K., T. I. Jeon, H. K. Chong, J. Biesinger, X. Xie, and T. F. Osborne. 2011. “Genome-Wide Localisation of SREBP-2 in Hepatic Chromatin Predicts a Role in Autophagy.” Cell Metabolism 13: 367–375. doi:10.1016/j.cmet.2011.03.005.
   PubMed Web of Science ®Google Scholar
• Shao, F., X. Wang, J. Yu, H. Jiang, B. Zhu, and Z. Gu. 2014. “Expression of miR-33 from an SREBF2 Intron Targets the FTO Gene in the Chicken.” PloS one 9: e91236. doi:10.1371/journal.pone.0091236.
   PubMed Web of Science ®Google Scholar
• Shin, D. J., and T. F. Osborne. 2003. “Thyroid Hormone Regulation and Cholesterol Metabolism are Connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2).” The Journal of Biological Chemistry 278: 34114–34118. doi:10.1074/jbc.M305417200.
   PubMed Web of Science ®Google Scholar
• Shukla, G. C., J. Singh, and S. Barik. 2011. “MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.” Molecular and Cellular Pharmacology 3: 83–92.
   PubMedGoogle Scholar
• Spiekerkoetter, U., B. Sun, Z. Khuchua, M. J. Bennett, and A. W. Strauss. 2003. “Molecular and Phenotypic Heterogeneity in Mitochondrial Trifunctional Protein Deficiency Due to Beta-Subunit Mutations.” Human Mutation 21: 598–607. doi:10.1002/humu.10211.
   PubMed Web of Science ®Google Scholar
• Wanders, R. J., S. Ferdinandusse, P. Brites, and S. Kemp. 2010. “Peroxisomes, Lipid Metabolism and Lipotoxicity.” Biochimica et biophysica acta 1801: 272–280. doi:10.1016/j.bbalip.2010.01.001.
   PubMed Web of Science ®Google Scholar
• Wang, D., M. Lu, J. Miao, T. Li, E. Wang, and Q. Cui. 2009. “Cepred: Predicting the Co-Expression Patterns of the Human Intronic microRNAs with Their Host Genes.” PloS one 4: e4421. doi:10.1371/journal.pone.0004421.
   PubMed Web of Science ®Google Scholar
• Zheng, Y., S. Jiang, Y. Zhang, R. Zhang, and D. Gong. 2015. “Detection of miR-33 Expression and the Verification of Its Target Genes in the Fatty Liver of Geese.” International Journal of Molecular Sciences 16: 12737–12752. doi:10.3390/ijms160612737.
   PubMed Web of Science ®Google Scholar